Imgn stock price target
Witryna10 kwi 2024 · With analysts defining $3.00-$22.00 as the low and high price targets, we arrive at a consensus price target of $12.00 for the trailing 12-month period. ... IMGN stock’s performance was 4.37% in the latest trading, and -26.71% in the past year, while Eli Lilly and Company (LLY) has traded 1.67% on the day and positioned 25.92% … WitrynaBased on 5 Wall Street analysts offering 12 month price targets for Celldex in the last 3 months. The average price target is $70.00 with a high forecast of $73.00 and a low forecast of $65.00 . The average price target represents a 126.10% change from the last price of $30.96 .
Imgn stock price target
Did you know?
WitrynaBusiness Wire. ImmunoGen, Inc., a commercial-stage biotechnology company, focuses on developing and commercializing the antibody-drug conjugates (ADCs) for … Witryna27 lut 2024 · With analysts defining $4.00-$22.00 as the low and high price targets, we arrive at a consensus price target of $12.10 for the trailing 12-month period. ... IMGN stock’s performance was -6.05% in the latest trading, and -22.13% in the past year, while Eli Lilly and Company (LLY) has traded -1.80% on the day and positioned 34.97% …
Witryna19 gru 2024 · ImmunoGen Inc (NASDAQ:IMGN) price targets, estimates; revenue, net income, and ebit forecast. WitrynaBased on short-term price targets offered by 10 analysts, the average price target for ImmunoGen comes to $10.40. The forecasts range from a low of $3.00 to a high of …
WitrynaImmunogen (IMGN) Stock Key Data. Summary Additional Data Analysts Historical Quotes. Key Data. ... Consensus Price Target is the stock price analysts expect to … WitrynaSee ImmunoGen, Inc. stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy. ... Price target. 12.10 …
WitrynaBased on short-term price targets offered by 10 analysts, the average price target for ImmunoGen comes to $10.40. The forecasts range from a low of $3.00 to a high of $19.00. The average price ...
Witryna3 lut 2024 · ImmunoGen, Inc. is a clinical-stage biotechnology company focused on developing the antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. An ADC with the Company’s technology comprises an antibody that binds to a target found on tumor cells and is conjugated to one of its potent anti-cancer … deshler rail cam live youtubeWitrynaBusiness Wire. ImmunoGen, Inc., a commercial-stage biotechnology company, focuses on developing and commercializing the antibody-drug conjugates (ADCs) for cancer patients. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), for the treatment of platinum-resistant ovarian … deshler public library ohioWitrynaAccording to . 6 Wall Street analysts that have issued a 1 year IMGN price target, the average IMGN price target is $12.83, with the highest IMGN stock price forecast at … chubbies shorts retail storeWitryna17 mar 2024 · The latest price target for . Immunogen (NASDAQ: IMGN) was reported by HC Wainwright & Co. on March 2, 2024.The analyst firm set a price target for … deshler public schools websiteWitrynaImmunogen (IMGN) Stock Key Data. Summary Additional Data Analysts Historical Quotes. Key Data. ... Consensus Price Target is the stock price analysts expect to see within a period of 0-18 months. chubbies shorts ownerWitryna6 kwi 2024 · Immunogen started at buy with $10 stock price target at Truist Nov. 21, 2024 at 7:42 a.m. ET by Tomi Kilgore ImmunoGen's stock is up 12% after the FDA accepts application for new ovarian-cancer ... chubbies shorts stockWitrynaImmunogen Inc. analyst ratings, historical stock prices, earnings estimates & actuals. IMGN updated stock price target summary. chubbies shorts san francisco